A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis

NCT02144285 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure, Chronic

Interventions

DRUG: LY3113593
DRUG: LY3113593
DRUG: Placebo
DRUG: Placebo

Sponsor

Eli Lilly and Company